Italian antitrust probe into Byooviz drugmakers pushed back to October
MLex Summary: The Italian competition authority has said that its investigation into several drugmakers — to see if they coordinated commercial strategies to delay the market entry of eye-disease treatment Byooviz...To view the full article, register now.
Already a subscriber? Click here to view full article